| |
| A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer: a Hellenic Cooperative Oncology Group study |
| Fountzilas G, Dafni U, Dimopoulos M A, Koutras A, Skarlos D, Papakostas P, Gogas H, Bafaloukos D, Kalogera-Fountzila A, Samantas E, Briasoulis E, Pectasides D, Maniadakis N, Matsiakou F, Aravantinos G, Papadimitriou C, Karina M, Christodoulou C, Kosmidis P, Kalofonos H P |
|
|
| |
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Fountzilas G, Dafni U, Dimopoulos M A, Koutras A, Skarlos D, Papakostas P, Gogas H, Bafaloukos D, Kalogera-Fountzila A, Samantas E, Briasoulis E, Pectasides D, Maniadakis N, Matsiakou F, Aravantinos G, Papadimitriou C, Karina M, Christodoulou C, Kosmidis P, Kalofonos H P. A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer: a Hellenic Cooperative Oncology Group study. Breast Cancer Research and Treatment 2009; 115(1): 87-99 Indexing Status Subject indexing assigned by NLM MeSH Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal /therapeutic use; Antibodies, Monoclonal, Humanized; Antineoplastic Agents /therapeutic use; Antineoplastic Combined Chemotherapy Protocols /therapeutic use; Breast Neoplasms /drug therapy /pathology; Carboplatin /therapeutic use; Deoxycytidine /administration & Female; Humans; Middle Aged; Neoplasm Metastasis; Paclitaxel /administration & Taxoids /administration & Trastuzumab; derivatives; dosage /analogs & dosage /therapeutic use; dosage /therapeutic use AccessionNumber 22009101754 Date bibliographic record published 07/10/2009 |
| |
|
|
